ABCL 8-K 2026-01-14

AbCellera Biologics Inc. (ABCL) 8-K dated 2026-01-14 — accession 0001703057-26-000003. This URL is the filing, not the ABCL hub.

AbCellera Biologics Inc. (ABCL) is a biotechnology company listed on US.

AbCellera Biologics Inc. filed a 8-K on 2026-01-14. Accession 0001703057-26-000003.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ABCL revenue for 2026-06-30 was $12.4M. Net income was -$98.6M. Revenue was up 48.7% from 2026-03-31 to 2026-06-30. ABCL currently screens at market cap $1.12B.

Not investment advice. The ABCL SEC hub lists recent forms. The stock page is the research view.